23.2.2022
•
News
Corporate law
Intellectual property
KSB Advises Mattoni 1873 on Joint Project with Budějovický Budvar
KSB's team (partner Dagmar Dubecká and associates Milada Kürtösiová and Ján Béreš) provided Mattoni 1873 with comprehensive legal advice during negotiations with Budějovický Budvar regarding a unique project for the production of flavoured non-alcoholic beer.
KSB helped to create the structure of, and drafted the contractual documentation for, the cooperation between the companies. KSB also designed solutions for their collaborative relationship regarding intellectual and industrial property, and assisted in negotiating the terms of the transaction and the final version of the contracts.
For details, read Mattoni 1873’s and Budějovický Budvar’s press releases, which are available here.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
